Replies to post #2942 on Jaguar Health Inc (JAGX)

[knrorrel]

JAGX good News straight out and few people have seen the news and after the strong downward push on $JAGX PPS there should now be a strong push upwards because the stock is heavily oversold and could have a good run https://www.stocktitan.net/news/JAGX/jaguar-health-announces-submission-of-orphan-drug-designation-mgce9nu7c3la.html 🥳🥳🥳

[oldstocks]

Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Products:
Mytesi Crofelemer 125mg delayed release tablets
Mytesi is FDA-approved for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy
Mytesi has a novel mechanism of action that modulates chloride secretion in the gastrointestinal tract, reducing excessive chloride and accompanying water flow and relieving watery diarrhea.
In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).